Association between antibiotic use and changes in susceptibility patterns of Pseudomonas aeruginosa in an intensive care burn unit: A 5-year study, 2000-2004

Burns

Volumn 34, Issue 8, 2008, Pages 1098-1102

  Messadi, Amen Allah ^a   Lamia, Thabet ^b   Kamel, Bousselmi ^a   Salima, Oueslati ^a   Monia, Memmi ^a   Saida, Ben Redjeb ^b  

^a Hopital Aziza Othmana   (Tunisia)

^b UNIVERSITY OF TUNIS EL MANAR   (Tunisia)

Author keywords

Antibiotic resistance; Antibiotic use; Pseudomonas aeruginosa

Indexed keywords

AMIKACIN; CEFOTAXIME; CEFTAZIDIME; CIPROFLOXACIN; GENTAMICIN; IMIPENEM; OFLOXACIN; PIPERACILLIN PLUS TAZOBACTAM;

ADULT; ANTIBIOTIC RESISTANCE; ARTICLE; BURN INFECTION; BURN UNIT; CONTROLLED STUDY; DISK DIFFUSION; FEMALE; HUMAN; INTENSIVE CARE UNIT; MALE; NONHUMAN; PSEUDOMONAS AERUGINOSA;

ADULT; ANTI-BACTERIAL AGENTS; BURN UNITS; BURNS; DISK DIFFUSION ANTIMICROBIAL TESTS; DRUG RESISTANCE, MULTIPLE, BACTERIAL; FEMALE; HUMANS; INTENSIVE CARE UNITS; MALE; PSEUDOMONAS AERUGINOSA; PSEUDOMONAS INFECTIONS; TUNISIA;

EID: 54449092255     PISSN: 03054179     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.burns.2008.03.014     Document Type: Article

References (23)

1. Hsueh P., Chen, and Luh K. Relationships between antimicrobial use and antimicrobial resistance in Gram negative bacteria causing nosocomial infections from 1991-2003 at a university hospital in Taiwan. Int J Antimicrob Agents 26 (2005) 463-472
2. Estahbanati H.K., Kashani P.P., and Ghanaatpisheh F. Frequency of Pseudomonas aeruginosa serotypes in burn wound infections and their resistance to antibiotics. Burns 28 (2002) 340-348
3. Altopark U., Erol S., Akcay M., Celebi F., and Kadanali A. The time related changes of antimicrobial resistance patterns and predominant bacterial profiles of burn wounds and body flora of burned patients. Burns 30 (2004) 660-664
4. Mohr A., Jones A., Zeichner L., Wanger A., and Tilloston G. Associations between antibiotic use and changes in susceptibility patterns of Pseudomonas aeruginosa in a private university affiliated teaching hospital: an 8 year experience: 1995-2002. Int J Antimicrob Agents (2004) 346-351
5. American College of Chest Physicians/Society of Critical Care Medicine Consensus Committee. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 20 (1992) 864
6. Soussy CJ. Comité de l'antibiogramme de la SFM. Bull Soc Fr Microbiol 2001.
7. www.who.int/drugresistance/whonet.
8. Mise en place d'un réseau de surveillance de la consommation des antibiotiques parallèlement à certaines résistances bactériennes dans les établissements de soins de l'inter région Paris Nord. Protocole ATB 2005, CCLIN Paris Nord. www.ccr.jussien.fr/cclin.
9. Rogues A.M., Dumartin C., Parneix P., Prudhan H., Placet Th., Beneteau C., et al. Policies for the use of antibiotics in 99 Southwestern French hospitals in 2002. Med Mal Infect (2005)
10. Carmeli Y., Trouillet N., Eliopoulos G., and Samore M. Emergence of antibiotic resistant Pseudomonas aeruginosa: comparison of risks associated with different antipseudomonal agents. AACN Clin Issues 43 (1999) 1379-1382
11. Lozzano J., Monnet D., Yague A., Campillos P., Gonzalo N., and Burgos A. Surveillance de la résistance bactérienne et modélisation de sa relation avec les consommations d'antibiotiques au moyen de l'analyse des séries chronologiques. Bull Soc Fr Microbiol (2002) 17
12. El Seviens M. Outpatient antibiotic use in Europe and association with resistance: a cross national database study. Lancet 365 (2005) 579-587
13. Nseir S., Dipompeo C., Soubrier S., Delour P., Lenci H., Roussel D., et al. First generation fluoroquinolone use and subsequent emergence of multiple drugs resistant in the intensive care unit. Crit Care Med 33 (2005) 283-289
14. Lepper P., Gruser E., Reich H., Hogel J., and Trautmann M. Consumption of imipenem correlates with β-lactam resistance in Ps. aeruginosa. AACN Clin Issues 46 (2002) 2920-2925
15. Lopez M., Dominique L., Yague A., Gonzelo N., Campillos P.S., and Saez M. Modelling and forecasting antimicrobial resistance and its dynamic relationship to antimicrobial use: a time series analysis. Int J Antimicrob Agents 14 (2000) 21-31
16. Neuhauser M.M., Weinstein R.A., Rydman R., Danziger L.H., and Quinn K. Antibiotic resistance among Gram negative bacilli in US intensive care units: implications for fluoroquinolone use. JAMA 289 (2003) 885-888
17. Polk R, Johnson C, Edmond M, Wenzel R. Trends in fluoroquinolone (FQ) prescribing in 35 US hospitals and resistance for Ps. aeruginosa: a scope MMIT report. Proceedings of the interscience conference on antimicrobial agents and chemotherapy. Chicago, IL: Chicago American Society for Microbiology; 2001 [Abstract UL-1].
18. Macdougall C., Harpe S., Powell J., Johnson C., Edmont M., and Polk R. Pseudomonas aeruginosa, Staphylococcus aureus and fluoroquinolone use. Emerg Infect Dis (2005) 11
19. Harbarth S., Harris A.D., Carmeli Y., and Samore M.H. Parallel analysis of individual and aggregated data on antibiotic exposure and resistance in gram negative bacilli. CID 33 (2001) 1462-1468
20. Trouillet J.L., Vuagnat A., Combes A., Kassis N., Chastre J., and Gibert C. Pseudomonas aeruginosa ventilator associated pneumonia: comparison of episodes due to piperacillin resistant versus piperacillin susceptible organisms. CID 34 (2002) 1047-1054
21. Monnet D.L., Archibald L.K., Phillips L., Tenover F.C., Mcgowan J., and Gaynes R. Antimicrobial use and resistance in eight US hospitals: complexities of analysis and modelling. Intensive Care Antimicrobial Resistance Epidemiology Project, and National Nosocomial Infections Surveillance System Hospitals. Infect Control Hosp Epidemiol 19 (1998) 388-394
22. Paramythiotou E., Lucet J., Timsit J., Vanjak D., Butz C., and Andremont A. Acquisition of multidrug resistant Ps. aeruginosa in patients in intensive care units: role of antibiotics with antipseudomonal activity. CID 38 (2004) 670-674
23. Seir N., Ader F., Marquette C.H., and Durocher A. Impact de l'utilisation des fluoroquinolones sur l'émergence des bactéries multirésistants. Pathol Biol (Paris) 53 (2005) 470-475